Abstract
Repair and regeneration of vascular tissue is a crucial current research focus in the fields of biomedical engineering and regenerative medicine. Numerous studies revealed that cells are required to grow on an appropriate extracellular matrix to maintain or enhance functionality. In the present study, various surface modification methods were evaluated to fix fibronectin on the surface of a bio-based and aligned poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) film for vascular tissue engineering. After chemical modification, the properties of the fibronectin-fixed PHBV films were examined and compared with the original films, including -NH2 group expression, contact angle, mechanical properties, and fibronectin binding amount. Then, cytotoxicity and biocompatibility were measured by culture with L929 cells and endothelial progenitor cells (EPCs) of the fibronectin-fixed PHBV films. In addition, cell morphology, cell growth kinetics, acetylated low-density lipoprotein uptake ability, lectin binding ability and specific gene expressions of cultured EPCs on fibronectin-fixed PHBV films were also analyzed. Taken together, our data demonstrated that the surface of the aligned PHBV films could be successfully modified to immobilize fibronectin. Importantly, EPCs cultured on the fibronectin-fixed PHBV films showed excellent cell biocompatibility, a rapid proliferation rate, an aligned growth direction and correct cell functions. We believed that fibronectin-fixed PHBV films can serve as a potential scaffold for vascular tissue engineering.
Similar content being viewed by others
References
De Bakey, M. E. and D. A. Cooley (1954) Successful resection of aneurysm of distal aortic arch and replacement by graft. J. Am. Med. Assoc. 155: 1398–1403.
Chlupáč, J., E. Filová, and L. Bačáková (2009) Blood vessel replacement: 50 years of development and tissue engineering paradigms in vascular surgery. Physiol. Res. 58(Suppl 2): S119–S139.
Veith, F. J., S. K. Gupta, E. Ascer, S. White-Flores, R. H. Samson, L. A. Scher, J. B. Towne, V. M. Bernhard, P. Bonier, W. R. Flinn, P. Astelford, J. S. T. Yao, and J. J. Bergan (1986) Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J. Vasc. Surg. 3: 104–114.
Aslani, S., M. Kabiri, M. Kehtari, and H. Hanaee-Ahvaz (2019) Vascular tissue engineering: Fabrication and characterization of acetylsalicylic acid-loaded electrospun scaffolds coated with amniotic membrane lysate. J. Cell. Physiol. 234: 16080–16096.
Braghirolli, D. I., V. E. Helfer, P. C. Chagastelles, T. P. Dalberto, D. Gamba, and P. Pranke (2017) Electrospun scaffolds functionalized with heparin and vascular endothelial growth factor increase the proliferation of endothelial progenitor cells. Biomed. Mater. 12: 025003.
Hsia, K., M. J. Yang, W. M. Chen, C. L. Yao, C. H. Lin, C. C. Loong, Y. L. Huang, Y. T. Lin, A. D. Lander, H. Lee, and J. H. Lu (2017) Sphingosine-1-phosphate improves endothelialization with reduction of thrombosis in recellularized human umbilical vein graft by inhibiting syndecan-1 shedding in vitro. Acta Biomater. 51: 341–350.
Serbo, J. V. and S. Gerecht (2013) Vascular tissue engineering: biodegradable scaffold platforms to promote angiogenesis. Stem Cell Res. Ther. 4: 8.
Dahl, S. L. M., A. P. Kypson, J. H. Lawson, J. L. Blum, J. T. Strader, Y. Li, R. J. Manson, W. E. Tente, L. DiBernardo, M. T. Hensley, R. Carter, T. P. Williams, H. L. Prichard, M. S. Dey, K. G. Begelman, and L. E. Niklason (2011) Readily available tissue-engineered vascular grafts. Sci. Transl. Med. 3: 68ra9.
Zhang, W. J., W. Liu, L. Cui, and Y. Cao (2007) Tissue engineering of blood vessel. J. Cell. Mol. Med. 11: 945–957.
Shin, Y. M., J.-Y. Lim, J.-S. Park, H.-J. Gwon, S. I. Jeong, and Y.-M. Lim (2014) Radiation-induced biomimetic modification of dual-layered nano/microfibrous scaffolds for vascular tissue engineering. Biotechnol. Bioprocess Eng. 19: 118–125.
Hoenig, M. R., G. R. Campbell, B. E. Rolfe, and J. H. Campbell (2005) Tissue-engineered blood vessels: alternative to autologous grafts? Arterioscler. Thromb. Vasc. Biol. 25: 1128–1134.
Gong, Z. and L. E. Niklason (2006) Blood vessels engineered from human cells. Trends Cardiovasc. Med. 16: 153–156.
Krause, D. S., N. D. Theise, M. I. Collector, O. Henegariu, S. Hwang, R. Gardner, S. Neutzel, and S. J. Sharkis (2001) Multiorgan, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369–377.
Khoo, C. P., P. Pozzilli, and M. R. Alison (2008) Endothelial progenitor cells and their potential therapeutic applications. Regen. Med. 3: 863–876.
Kim, J., K. Yang, H.-J. Park, S.-W. Cho, S. Han, Y. Shin, S. Chung, and J. H. Lee (2014) Implantable microfluidic device for the formation of three-dimensional vasculature by human endothelial progenitor cells. Biotechnol. Bioprocess Eng. 19: 379–385.
Rammal, H., C. Harmouch, J. J. Lataillade, D. Laurent-Maquin, P. Labrude, P. Menu, and H. Kerdjoudj (2014) Stem cells: a promising source for vascular regenerative medicine. Stem Cells Dev. 23: 2931–2949.
Paprocka, M., A. Krawczenko, D. Dus, A. Kantor, A. Carreau, C. Grillon, and C. Kieda (2011) CD133 positive progenitor endothelial cell lines from human cord blood. Cytometry A 79: 594–602.
Duan, H. X., L. M. Cheng, J. Wang, L. S. Hu, and G. X. Lu (2006) Angiogenic potential difference between two types of endothelial progenitor cells from human umbilical cord blood. Cell Biol. Int. 30: 1018–1027.
Krenning, G., M. J. van Luyn, and M. C. Harmsen (2009) Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol. Med. 15: 180–189.
Asahara, T., T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman, and J. M. Isner (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964–967.
Janic, B., A. M. Guo, A. S. Iskander, N. R. Varma, A. G. Scicli, and A. S. Arbab (2010) Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion. PLoS One 5: e9173.
Cheng, S. L., C. H. Lin, and C. L. Yao (2017) Mesenchymal stem cell administration in patients with chronic obstructive pulmonary disease: state of the science. Stem Cells Int. 2017: 8916570.
Lin, K. H., Y. H. Ho, J. C. Chiang, M. W. Li, S. H. Lin, W. M. Chen, C. L. Chiang, Y. N. Lin, Y. J. Yang, C. N. Chen, J. Lu, C. J. Huang, G. Tigyi, C. L. Yao, and H. Lee (2016) Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis. Sci. Rep. 6: 27050.
Kao, I. T., C. L. Yao, Y. J. Chang, T. B. Hsieh, and S. M. Hwang (2008) Chondrogenic differentiation of human mesenchymal stem cells from umbilical cord blood in chemically synthesized thermoreversible polymer. Chin. J. Physiol. 51: 252–258.
Smadja, D. M., A. Cornet, J. Emmerich, M. Aiach, and P. Gaussem (2007) Endothelial progenitor cells: characterization, in vitro expansion, and prospects for autologous cell therapy. Cell Biol. Toxicol. 23: 223–239.
Marchand, M., E. K. Anderson, S. M. Phadnis, M. T. Longaker, J. P. Cooke, B. Chen, and R. A. Reijo Pera (2014) Concurrent generation of functional smooth muscle and endothelial cells via a vascular progenitor. Stem Cells Transl. Med. 3: 91–97.
Li, H., R. Du, and J. Chang (2005) Fabrication, characterization, and in vitro degradation of composite scaffolds based on PHBV and bioactive glass. J. Biomater. Appl. 20: 137–155.
Chen, G. Q. and Q. Wu (2005) The application of polyhydroxy-alkanoates as tissue engineering materials. Biomaterials 26: 6565–6578.
Wollenweber, M., H. Domaschke, T. Hanke, S. Boxberger, G. Schmack, K. Gliesche, D. Scharnweber, and H. Worch (2006) Mimicked bioartificial matrix containing chondroitin sulphate on a textile scaffold of poly(3-hydroxybutyrate) alters the differentiation of adult human mesenchymal stem cells. Tissue Eng. 12: 345–359.
Qu, X. H., Q. Wu, K. Y. Zhang, and G. Q. Chen (2006) In vivo studies of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) based polymers: biodegradation and tissue reactions. Biomaterials 27: 3540–3548.
Li, J., H. Yun, Y. Gong, N. Zhao, and X. Zhang (2005) Effects of surface modification of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) on physicochemical properties and on interactions with MC3T3-E1 cells. J. Biomed. Mater. Res. A 75: 985–998.
Qu, X. H., Q. Wu, J. Liang, X. Qu, S. G. Wang, and G. Q. Chen (2005) Enhanced vascular-related cellular affinity on surface modified copolyesters of 3-hydroxybutyrate and 3-hydroxyhexanoate (PHBHHx). Biomaterials 26: 6991–7001.
Yao, C.-L., J.-H. Chen, and C.-H. Lee (2018) Effects of various monomers and micro-structure of polyhydroxyalkanoates on the behavior of endothelial progenitor cells and endothelial cells for vascular tissue engineering. J. Polym. Res. 25: 187.
Frantz, C., K. M. Stewart, and V. M. Weaver (2010) The extracellular matrix at a glance. J. Cell Sci. 123: 4195–4200.
Shen, Z., C. Kang, J. Chen, D. Ye, S. Qiu, S. Guo, and Y. Zhu (2013) Surface modification of polyurethane towards promoting the ex vivo cytocompatibility and in vivo biocompatibility for hypopharyngeal tissue engineering. J. Biomater. Appl. 28: 607–616. (Erratum published 2014, J. Biomater. Appl. 28: 798)
Chang, K. Y., L. H. Hung, I. M. Chu, C. S. Ko, and Y. D. Lee (2010) The application of type II collagen and chondroitin sulfate grafted PCL porous scaffold in cartilage tissue engineering. J. Biomed. Mater. Res. A 92: 712–723.
García-García, J. M., I. Quijada-Garrido, L. López, R. París, M. T. Núñez-López, E. de la Peña Zarzuelo, and L. Garrido (2013) The surface modification of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) copolymers to improve the attachment of urothelial cells. Mater. Sci. Eng. C Mater. Biol. Appl. 33: 362–369.
Hinüber, C., K. Chwalek, F. J. Pan-Montojo, M. Nitschke, R. Vogel, H. Brünig, G. Heinrich, and C. Werner (2014) Hierarchically structured nerve guidance channels based on poly-3-hydroxybutyrate enhance oriented axonal outgrowth. Acta Biomater. 10: 2086–2095.
Wang, L.-Y., Y.-J. Wang, and D.-R. Cao (2009) Surface modification of poly(3-hydroxybutyrate-co-3-hydroxyvalerate) membrane by combining surface aminolysis treatment with collagen immobilization. J. Macromol. Sci. Part A-Pure Appl. Chem. 46: 765–773.
Hsu, S. H., T. T. Ho, N. C. Huang, C. L. Yao, L. H. Peng, and N. T. Dai (2014) Substrate-dependent modulation of 3D spheroid morphology self-assembled in mesenchymal stem cell-endothelial progenitor cell coculture. Biomaterials 35: 7295–7307.
Lai, C.-C., M.-Y. Chung, and C.-T. Lo (2017) Nitric acid oxidation of electrospun carbon nanofibers as supercapacitor electrodes. Text. Res. J. 87: 2337–2348.
Hsia, K., C. L. Yao, W. M. Chen, J. H. Chen, H. Lee, and J. H. Lu (2016) Scaffolds and cell-based tissue engineering for blood vessel therapy. Cells Tissues Organs 202: 281–295.
Acknowledgements
This work was supported by the Ministry of Science and Technology, Taiwan, Republic of China (MOST 108-2628-E-006-009-MY3) and Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan, Republic of China (PTH111033).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare no conflicts of interest.
Neither ethical approval nor informed consent was required for this study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Hsu, CN., Lin, YT., Chen, YH. et al. An Aligned Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Scaffold Fixed with Fibronectin to Enhance the Attachment and Growth of Human Endothelial Progenitor Cells. Biotechnol Bioproc E 28, 428–438 (2023). https://doi.org/10.1007/s12257-022-0255-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-022-0255-x